Highest-materiality recent filing
All eight director nominees elected with 92-98% support; broker non-votes ~2M shares.
PHINIA Q1 sales $878M (+10.3% YoY), adj. EPS $1.29 (+37%), reaffirms FY outlook
Net sales $878M (+10.3% YoY); net earnings $37M (margin 4.2%); adjusted EBITDA $115M (margin 13.1%).
PHINIA completes auditor change from PwC to D&T; dismissal effective Feb 12, 2026
PwC dismissal effective Feb 12, 2026 upon filing of FY 2025 10-K and completion of its procedures.
PHINIA Q4 2025 net sales $889M (+6.7% YoY), guided FY2026 EBITDA $485-525M
Q4 net sales $889M (+6.7% YoY); net earnings $45M vs $5M; adj. EPS $1.18.
PHINIA appoints Deloitte & Touche as auditor for FY2026; PwC dismissed
Audit Committee approved Deloitte & Touche as independent auditor for fiscal year ending Dec 31, 2026, after competitive process.
Net sales of $908 million, an increase of 8.2% compared with Q3 2024, driven by pricing, tariff recoveries, and higher volumes in Asia and Americas.
PHINIA settles tax dispute with BorgWarner, records $39M loss in Q3 2025
PHINIA to pay BorgWarner $78M total: $31M in Q4 2025, $21M in Q1 2026, $26M as refunds received.
PHINIA Q2 net sales $890M, adj EPS $1.27; acquires SEM for $47M; FY adj EBITDA guide $455-485M
Net sales $890M (+2.5% YoY), net earnings $46M, adj EBITDA $126M (14.2% margin).
PHINIA shareholders elect all directors, approve say-on-pay and auditor at annual meeting
All eight director nominees elected with over 97% of votes cast in favor, including Samuel R. Chapin, Brady D. Ericson, Robin Kendrick, and others.
PHINIA Q1 sales down 7.8% to $796M; adjusted EBITDA margin 12.9% down 260 bps
Net earnings $26M ($0.63 diluted EPS); adjusted EPS $0.94, reflecting lower sales and tariff impacts.
PHINIA Q4 adj EPS $0.71; dividend raised 8% to $0.27; $200M buyback increase; 2025 guidance soft
Q4 net sales $833M (-5.6% YoY); adj EPS $0.71 vs $0.87 a year ago.
PHINIA Q3 net sales down 6.4%; adjusted EBITDA margin up 90 bps; lowers FY2024 sales guidance
Q3 net sales $839M (-6.4% YoY); adjusted sales ex-contract mfg $838M (-3.7% YoY). Net income $31M vs $1M loss in Q3 2023.
PHINIA issues $450M 6.625% Senior Notes due 2032 (upsized from $400M); amends credit agreement
Issued $450M aggregate principal of 6.625% Senior Notes due Oct 15, 2032; increased from previously announced $400M.
PHINIA prices $450M of 6.625% senior notes due 2032, upsized from $400M
Offering increased to $450M from originally announced $400M; priced at 100.00% plus accrued interest.
PHINIA appoints Meggan Walsh to Board Corporate Governance Committee, grants 2,748 RSUs
Meggan Walsh appointed to Corporate Governance Committee effective August 1, 2024.
PHINIA Q2 sales $868M (-2.1% YoY), net earnings $14M, EPS $0.31; adjusted EPS $0.88
Net sales $868M, down 2.1% YoY; operating income $71M (+$15M YoY), operating margin 8.2%.
PHINIA elects Meggan Walsh to Board effective July 1; board expands to 8 members
Board increased from 7 to 8 directors; Meggan M. Walsh elected to fill the vacancy.
PHINIA annual meeting results: all director nominees elected, say-on-pay approved
All seven director nominees elected with ~35M votes each; no major opposition.
PHINIA Q1 sales up 3.4% to $863M; adjusted EPS $1.08, reaffirms FY2024 outlook
Net sales $863M (+3.4% YoY); adjusted net earnings $1.08 per diluted share vs GAAP $0.62.
On June 19, 2024, the Board of Directors (the “Board”) of PHINIA Inc. (the “Company”) increased the size of the Board from seven to eight members and elected Meggan M. Walsh to fill the resulting vacancy, each effective July 1, 2024 (the “Effective Date”).
Max materiality 0.90 · Median 0.70 · Most common event earnings